Isomorphic Labs Eyes $40 Billion Valuation in Fresh Funding Round
Isomorphic Labs, a UK‑based AI drug‑discovery spin‑out of Alphabet’s DeepMind, is reportedly in preliminary discussions to secure fresh capital that would value the company at no less than $40 billion.